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Summary.-Serum IgG, IgM and IgA levels were measured by the single radial
diffusion method in 107 South African Negro patients with primary hepatocellular
cancer (PHC) and 112 healthy Negro blood donors. The mean serum IgG and IgM
concentrations were significantly higher (P < 0.001) in the PHC patients. In those
patients in whom PHC was associated with cirrhosis, the serum IgG level was
greater (P < 0.02) than in those without cirrhosis. However, the mean serum IgG
concentration in the non-cirrhotic cancer patients was still significantly higher than
the control value (P < 0.001). Thus, while cirrhosis may contribute to the raised
IgG levels in PHC, other factors must also be involved. There was no difference in
the serum immunoglobulin concentrations in PHC patients with and without hepa-
titis-B antigenaemia.
THE FEW studies which have been
published on serum immunoglobulin
levels in primary hepatocellular cancer
(PHC) have yielded conflicting results.
Moreover, in those investigations in which
raised levels have been found, the import-
ance of cirrhosis, which is known to cause
changes in the serum IgG and IgM con-
centrations (Feizi, 1968; Chew, Yu and
Wee, 1970) and which is frequently associ-
ated with PHC (Sagebiel, McFarland and
Taft, 1963; Lin, 1970), as a cause for these
changes has not been established. Thus,
Primack, Vogel and Barker (1973) found
serum immunoglobulin levels to be no
higher than those in control subjects,
and that there was no difference between
the concentrations in PHC patients with
and without underlying cirrhosis. By
contrast, Akdamar et al. (1972) and Hira-
yama et al. (1972) reported raised levels.
The latter authors noted a relationship
between elevated immunoglobulin con-
centrations and the presence of hepatitis-
B (hepatitis-associated) antigen which
they believed to be related to the
presence of concomitant cirrhosis.
We report here our findings in South
African Negro patients with PHC and
discuss the relationship between the
serum immunoglobulin levels and the
presence or absence of both underlying
cirrhosis and hepatitis-B antigenaemia.
PATIENTS AND METHODS
The studywasbasedon 107Negrosubjects
with histologically proven PHC. The
patients, all of whom were males, were
between the ages of 20 and 50 years. Blood
was taken at the time of diagnosis and
before treatment was started. Serum IgG,
IgM and IgA levels were determined by the
single radial diffusion method using Behring-
werke Ag Tri-Partigen immunodiffusion
plates. In 18 patients these measurements
were repeated at weekly intervals until they
either died (14 patients) or refused further
treatment and were sent home (4 patients).
The mean period of follow up was 8 weeks,
with a range of 4-25 weeks. Seventeen of
these patients received chemotherapy (either
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CCNU (1-(2-chloroethyl)-3-(4-methylcyclo-
hexyl)-1-nitrosourea) or MECCNU (1-(2-
chloroethyl)-3-cyclohexyl-1-nitrosourea)) and
one radiotherapy during this time.
The pre3ence or absence ofthe hepatitis-B
(surface) antigen (HBsAg) in each patient's
serum was determined using counter immuno-
electrophoresis (Gocke and Howe, 1970) and
solid phase radioimmunoassay (Ausria 1-125;
Abbott) (Ling and Overby, 1972). Necrop-
sies were performed in 44 patients. In these
cases the presence or absence of underlying
cirrhosis could be established with certainty.
The normal levels of serum IgG, IgM and
IgA were determined in 112 apparently
healthy age-matched Negro male blood
donors. Both the cancer patients and the
controls were mine labourers.
RESULTS
The mean serum IgG and IgM levels
were significantly higher (P<0-001) in
the patients with PHC than in the controls
(Table). There was, however, a wide
range in the values of both immunoglobu-
lins in the cancer patients. The mean
serum IgA concentration was similar in
the 2 groups (Table). In the 18 patients
in whom serialestimationswereperformed,
there was no significant change between
the mean of the first and the last levels
of IgG, IgM or IgA (Table).
HB5Ag was detected in the serum of
63 of the patients (60% of the series).
The serum IgG, IgM and IgA levels were
not significantly different in PHC patients
with and without detectable hepatitis-B
antigenaemia (Table).
Macronodular cirrhosis was present in
20 of44patients (48%) inwhomanecropsy
was performed. The mean serum IgG
concentration was significantly higher
(P<0*02) in the PHC patients with cir-
rhosis than in those without (Table).
Serum IgM and IgA levels were not sig-
nificantly different in the 2 groups (Table).
The mean serum IgG concentration in
the non-cirrhotic cancer patients was
significantly higher than those in the
controls (P<0-001).
DISCUSSION
We have found serum IgG and IgM
levels to be significantly raised in South
African Negro patients with PHC.
Because the serum concentrations of
these immunoglobulins are elevated in
cirrhosis (Feizi, 1968; Chew et al., 1970)
and because PHC is frequently associated
with cirrhosis (the incidence in Southern
African Negroes with PHC is 50-600/,
(Kew et al., 1974)), it has been suggested
(Hirayama et al., 1972) that the raised
levels may be due to the underlying liver
disease rather than the tumour per se.
Our findings indicate that while cirrhosis
may contribute to the elevated IgG levels
in PHC, other factors are also involved,
as shown by the observation that the
levels in PHC patients without cirrhosis
were also significantly greater than those
in the control subjects. Furthermore, the
presence or absence of cirrhosis did not
have a bearing on the raised serum IgM
levels.
Persistence of the hepatitis-B virus
(HBV) in the liver may cause chronic
active hepatitis, cirrhosis and, perhaps
TABLE.-A & B: Serum Immunglobulin Levels in 107 Patients wvith PHC and 112 Healthy
Blood Donors. C & D: Comparison between Initial and Last Levels in 18 Patients in
Whom Serial Determinations were Performed. E & F: Relationship between Serum
Immunogl,obulin Levels and Hepatitis-B Antigenaemia. G & H: Relationship between
Serum Immunoglobulin Levels and Underlying Cirrhosis
A B C D E F G H
Primary HB,Ag- HBSAg- No
liver cancer Controls First level Last level Positive Negative Cirrhosis cirrhosis
IgG 2714±770* 1549+280 2564±851 2598+782 2773±7472574±809 2919±646t 2369+875
IgM 256±207* 151±77 173196 171±104 262±195 219±155 203±174 179±85
IgA 468±247 430 161 453 236 536±279 487±269 441±213 504±214 517±378
*P <0-001
tP <0-02
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ultimately PHC (Wright, McCollum and
Klatskin, 1969; Sherlock et al., 1970).
Hirayama et al. (1972) found anassociation
between elevated serum immunoglobulin
levels in PHC and the presence of HBAg
in the patients' serum, and assumed that
this could be explained if HBV was res-
ponsible for the cirrhosis. Since PHC
patients with persistent hepatitis-B
antigenaemia need not have cirrhosis
(Kew et al., 1974), an alternative explan-
ation for this finding is that raised IgGx
and IgM levels may reflect an immuno-
logical reaction to the virus itself. How-
ever, we have been unable to find any,
difference in serum immunoglobulin con-
centrations in PHC patients with and
without HBsAg. The reason for the
elevated serum IgG and IgM levels in
patients with PHC remains unknown.
We are indebted to the Director of the
South African Institute for Medical
Research for facilities granted.
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